Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market

The monopoly that Pfizer Inc., Merck & Co. Inc., Sanofi and GlaxoSmithKline plc (GSK) have on the vaccine market is unlikely to be broken, according to Jeffrey Holford, an equity analyst at global investment banking firm Jefferies.1 That market is projected to grow from $28.3 billion in 2015 to $72.5 billion in 2024.

Click this link to read the full story: Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market

Please follow and like us:

Leave a Reply